Gene Symbol | Gene ID | Gene Info |
---|---|---|
ETV1
|
ENSG00000006468.9 | ETS variant transcription factor 1 |
ERF
|
ENSG00000105722.5 | ETS2 repressor factor |
FEV
|
ENSG00000163497.2 | FEV transcription factor, ETS family member |
ELF1
|
ENSG00000120690.9 | E74 like ETS transcription factor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr13_41539133_41539284 | ELF1 | 17210 | 0.177809 | -0.84 | 4.7e-03 | Click! |
chr13_41533248_41533399 | ELF1 | 23095 | 0.161741 | -0.83 | 5.6e-03 | Click! |
chr13_41537663_41537814 | ELF1 | 18680 | 0.173864 | -0.80 | 9.3e-03 | Click! |
chr13_41594192_41594386 | ELF1 | 839 | 0.631268 | -0.79 | 1.2e-02 | Click! |
chr13_41538107_41538308 | ELF1 | 18211 | 0.175129 | -0.78 | 1.3e-02 | Click! |
chr19_42758329_42758480 | ERF | 353 | 0.648424 | -0.89 | 1.3e-03 | Click! |
chr19_42759537_42759765 | ERF | 342 | 0.453552 | -0.86 | 2.7e-03 | Click! |
chr19_42759860_42760096 | ERF | 669 | 0.341712 | -0.84 | 4.8e-03 | Click! |
chr19_42758839_42758990 | ERF | 127 | 0.747435 | -0.81 | 8.8e-03 | Click! |
chr19_42760150_42760301 | ERF | 916 | 0.275186 | -0.74 | 2.2e-02 | Click! |
chr7_14030181_14030332 | ETV1 | 614 | 0.808970 | -0.97 | 1.7e-05 | Click! |
chr7_14029472_14030001 | ETV1 | 94 | 0.980404 | -0.86 | 2.7e-03 | Click! |
chr7_14030471_14030874 | ETV1 | 202 | 0.961294 | -0.85 | 3.6e-03 | Click! |
chr7_14019488_14019639 | ETV1 | 6503 | 0.284428 | 0.83 | 5.8e-03 | Click! |
chr7_14028671_14029238 | ETV1 | 337 | 0.922069 | -0.83 | 5.8e-03 | Click! |
chr2_219848733_219848953 | FEV | 1536 | 0.214540 | -0.90 | 8.4e-04 | Click! |
chr2_219849042_219849790 | FEV | 963 | 0.351188 | -0.81 | 8.1e-03 | Click! |
chr2_219850396_219850547 | FEV | 92 | 0.932211 | -0.79 | 1.1e-02 | Click! |
chr2_219846310_219846631 | FEV | 3909 | 0.109266 | -0.76 | 1.7e-02 | Click! |
chr2_219844418_219844828 | FEV | 5756 | 0.096926 | -0.75 | 2.1e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr6_5582433_5582584 | 3.68 |
RP1-256G22.2 |
|
112997 |
0.06 |
chr1_20062070_20062221 | 2.79 |
TMCO4 |
transmembrane and coiled-coil domains 4 |
63692 |
0.08 |
chr1_114858576_114858727 | 2.51 |
TRIM33 |
tripartite motif containing 33 |
147207 |
0.04 |
chr7_143891861_143892598 | 2.48 |
RP4-545C24.1 |
|
185 |
0.77 |
chr2_179729003_179729154 | 2.43 |
CCDC141 |
coiled-coil domain containing 141 |
20600 |
0.17 |
chr7_157405725_157406364 | 2.37 |
AC005481.5 |
Uncharacterized protein |
671 |
0.75 |
chr10_119236354_119236505 | 2.35 |
EMX2OS |
EMX2 opposite strand/antisense RNA |
255 |
0.95 |
chr7_144052635_144053360 | 2.34 |
OR2A1-AS1 |
OR2A1 antisense RNA 1 |
197 |
0.79 |
chr14_69015321_69015580 | 2.22 |
CTD-2325P2.4 |
|
79712 |
0.1 |
chr15_90577870_90579058 | 2.13 |
ENSG00000265871 |
. |
28477 |
0.12 |
chr17_79544376_79544572 | 2.13 |
ENSG00000207021 |
. |
3958 |
0.12 |
chr10_13816413_13816564 | 2.08 |
RP11-353M9.1 |
|
45105 |
0.11 |
chr11_121336559_121337538 | 2.07 |
RP11-730K11.1 |
|
13326 |
0.24 |
chr19_18589481_18589960 | 2.05 |
ELL |
elongation factor RNA polymerase II |
2977 |
0.14 |
chr7_97958337_97958488 | 2.05 |
RP11-307C18.1 |
|
6247 |
0.2 |
chr1_17914051_17914202 | 1.96 |
ARHGEF10L |
Rho guanine nucleotide exchange factor (GEF) 10-like |
785 |
0.75 |
chr3_187286213_187286364 | 1.95 |
SST |
somatostatin |
101899 |
0.07 |
chr6_10426428_10427175 | 1.94 |
TFAP2A |
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
6930 |
0.18 |
chr17_79677505_79678358 | 1.87 |
SLC25A10 |
solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10 |
1406 |
0.21 |
chr7_150784838_150785537 | 1.86 |
AGAP3 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 |
1033 |
0.32 |
chr11_65220400_65220767 | 1.85 |
AP000769.1 |
Uncharacterized protein |
2145 |
0.21 |
chr5_114712845_114712996 | 1.83 |
CCDC112 |
coiled-coil domain containing 112 |
80392 |
0.09 |
chr18_54190735_54190886 | 1.82 |
TXNL1 |
thioredoxin-like 1 |
90912 |
0.09 |
chr5_168549003_168549154 | 1.81 |
CTB-174D11.1 |
|
91635 |
0.09 |
chr5_60921647_60922495 | 1.80 |
C5orf64 |
chromosome 5 open reading frame 64 |
11565 |
0.22 |
chr10_74282975_74283126 | 1.77 |
MICU1 |
mitochondrial calcium uptake 1 |
644 |
0.71 |
chr12_106475754_106475905 | 1.73 |
NUAK1 |
NUAK family, SNF1-like kinase, 1 |
1982 |
0.4 |
chr3_64206079_64206230 | 1.72 |
PRICKLE2 |
prickle homolog 2 (Drosophila) |
4977 |
0.24 |
chr1_39974930_39975642 | 1.71 |
RP11-69E11.4 |
|
15262 |
0.14 |
chr5_150403062_150403457 | 1.68 |
GPX3 |
glutathione peroxidase 3 (plasma) |
1646 |
0.38 |
chr4_114394825_114395109 | 1.68 |
CAMK2D |
calcium/calmodulin-dependent protein kinase II delta |
40031 |
0.16 |
chr1_157981064_157981318 | 1.67 |
KIRREL-IT1 |
KIRREL intronic transcript 1 (non-protein coding) |
14149 |
0.2 |
chr4_169543840_169543991 | 1.67 |
PALLD |
palladin, cytoskeletal associated protein |
8851 |
0.22 |
chr1_157971356_157971700 | 1.66 |
KIRREL |
kin of IRRE like (Drosophila) |
8093 |
0.22 |
chr8_1941875_1942026 | 1.63 |
KBTBD11 |
kelch repeat and BTB (POZ) domain containing 11 |
19906 |
0.23 |
chr14_51239824_51239975 | 1.63 |
NIN |
ninein (GSK3B interacting protein) |
6386 |
0.18 |
chr3_13580570_13580721 | 1.62 |
FBLN2 |
fibulin 2 |
6821 |
0.24 |
chr7_55178324_55178475 | 1.61 |
EGFR |
epidermal growth factor receptor |
859 |
0.73 |
chr6_111914585_111914879 | 1.60 |
C6orf3 |
|
6346 |
0.18 |
chr2_151330367_151330518 | 1.60 |
RND3 |
Rho family GTPase 3 |
11454 |
0.32 |
chr12_15784371_15784522 | 1.58 |
EPS8 |
epidermal growth factor receptor pathway substrate 8 |
30762 |
0.18 |
chr12_6320543_6320694 | 1.57 |
CD9 |
CD9 molecule |
10655 |
0.18 |
chr12_50641671_50641822 | 1.57 |
LIMA1 |
LIM domain and actin binding 1 |
1930 |
0.23 |
chr5_53821237_53821474 | 1.54 |
SNX18 |
sorting nexin 18 |
7762 |
0.29 |
chrX_39949861_39950479 | 1.54 |
BCOR |
BCL6 corepressor |
6486 |
0.33 |
chr1_245970690_245971117 | 1.52 |
RP11-522M21.3 |
|
131123 |
0.05 |
chr1_16508178_16508413 | 1.51 |
ARHGEF19-AS1 |
ARHGEF19 antisense RNA 1 |
16054 |
0.1 |
chr7_93698470_93698621 | 1.50 |
BET1 |
Bet1 golgi vesicular membrane trafficking protein |
64851 |
0.12 |
chr19_55663404_55663555 | 1.50 |
TNNT1 |
troponin T type 1 (skeletal, slow) |
2757 |
0.12 |
chr18_55584013_55584164 | 1.49 |
ENSG00000265200 |
. |
100028 |
0.07 |
chr1_220543285_220543436 | 1.49 |
AC096644.1 |
Uncharacterized protein |
64663 |
0.12 |
chr5_149539504_149539655 | 1.48 |
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
4156 |
0.17 |
chr2_69049514_69049665 | 1.47 |
ARHGAP25 |
Rho GTPase activating protein 25 |
5755 |
0.21 |
chr17_37031602_37032373 | 1.47 |
LASP1 |
LIM and SH3 protein 1 |
1844 |
0.19 |
chr8_41657091_41657242 | 1.47 |
ANK1 |
ankyrin 1, erythrocytic |
2026 |
0.3 |
chr2_192330541_192330692 | 1.46 |
MYO1B |
myosin IB |
54825 |
0.16 |
chr17_36862672_36863533 | 1.46 |
CTB-58E17.3 |
|
588 |
0.44 |
chr20_2187871_2188239 | 1.46 |
ENSG00000263452 |
. |
50128 |
0.14 |
chr1_6333311_6333462 | 1.46 |
GPR153 |
G protein-coupled receptor 153 |
12351 |
0.13 |
chr9_101595464_101595615 | 1.46 |
RP11-92C4.3 |
|
16356 |
0.18 |
chr5_152825461_152825612 | 1.46 |
GRIA1 |
glutamate receptor, ionotropic, AMPA 1 |
44570 |
0.21 |
chr2_43273247_43273788 | 1.45 |
ENSG00000207087 |
. |
45115 |
0.19 |
chr18_46449398_46450165 | 1.45 |
SMAD7 |
SMAD family member 7 |
25094 |
0.21 |
chr10_103825823_103826651 | 1.45 |
HPS6 |
Hermansky-Pudlak syndrome 6 |
1090 |
0.45 |
chr4_95563465_95563616 | 1.44 |
BMPR1B |
bone morphogenetic protein receptor, type IB |
115579 |
0.07 |
chr10_125690563_125690714 | 1.44 |
RP11-285A18.2 |
|
475 |
0.83 |
chr17_79195686_79196550 | 1.44 |
AZI1 |
5-azacytidine induced 1 |
612 |
0.56 |
chr6_106636060_106636211 | 1.43 |
RP1-134E15.3 |
|
88120 |
0.07 |
chr14_95066944_95067095 | 1.42 |
SERPINA3 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
11695 |
0.16 |
chr21_47714776_47715544 | 1.42 |
YBEY |
ybeY metallopeptidase (putative) |
8601 |
0.11 |
chr21_36217039_36217945 | 1.40 |
RUNX1 |
runt-related transcription factor 1 |
41988 |
0.19 |
chr7_2558193_2558548 | 1.40 |
LFNG |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
182 |
0.93 |
chr10_95140860_95141011 | 1.40 |
MYOF |
myoferlin |
101016 |
0.07 |
chr3_194294141_194294292 | 1.40 |
TMEM44-AS1 |
TMEM44 antisense RNA 1 |
10524 |
0.15 |
chr19_19510818_19511425 | 1.39 |
CTB-184G21.3 |
|
2291 |
0.22 |
chr14_101013755_101014380 | 1.39 |
BEGAIN |
brain-enriched guanylate kinase-associated |
368 |
0.82 |
chr11_122513915_122514066 | 1.38 |
UBASH3B |
ubiquitin associated and SH3 domain containing B |
12393 |
0.24 |
chr10_118894141_118894603 | 1.37 |
VAX1 |
ventral anterior homeobox 1 |
3195 |
0.23 |
chr3_99379303_99379454 | 1.37 |
COL8A1 |
collagen, type VIII, alpha 1 |
21924 |
0.22 |
chr10_118976365_118977069 | 1.37 |
KCNK18 |
potassium channel, subfamily K, member 18 |
19717 |
0.15 |
chr12_127153908_127154059 | 1.36 |
ENSG00000239776 |
. |
496689 |
0.0 |
chr15_93572424_93572985 | 1.36 |
CHD2 |
chromodomain helicase DNA binding protein 2 |
20608 |
0.22 |
chr9_14159514_14159665 | 1.36 |
NFIB |
nuclear factor I/B |
21202 |
0.29 |
chr5_175625830_175626529 | 1.36 |
SIMC1 |
SUMO-interacting motifs containing 1 |
39186 |
0.15 |
chr6_106583587_106583738 | 1.36 |
RP1-134E15.3 |
|
35647 |
0.17 |
chr18_56700627_56700778 | 1.35 |
SEC11C |
SEC11 homolog C (S. cerevisiae) |
106007 |
0.06 |
chr3_134044981_134045468 | 1.35 |
AMOTL2 |
angiomotin like 2 |
45530 |
0.15 |
chr3_188680922_188681073 | 1.33 |
TPRG1 |
tumor protein p63 regulated 1 |
15994 |
0.3 |
chr19_19335833_19336621 | 1.33 |
NCAN |
neurocan |
1591 |
0.22 |
chr20_17660563_17661274 | 1.33 |
RRBP1 |
ribosome binding protein 1 |
1787 |
0.38 |
chr3_50231195_50231703 | 1.31 |
GNAT1 |
guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 1 |
1344 |
0.29 |
chr19_31557934_31558085 | 1.30 |
AC020952.1 |
Uncharacterized protein |
82353 |
0.11 |
chrX_9875291_9875592 | 1.30 |
SHROOM2 |
shroom family member 2 |
4971 |
0.24 |
chr10_116616878_116617029 | 1.30 |
FAM160B1 |
family with sequence similarity 160, member B1 |
3597 |
0.33 |
chr19_48973435_48974073 | 1.30 |
CTC-273B12.5 |
|
804 |
0.33 |
chr4_140164132_140164283 | 1.29 |
ENSG00000252362 |
. |
11934 |
0.13 |
chr20_47887160_47887366 | 1.28 |
ZNFX1 |
zinc finger, NFX1-type containing 1 |
497 |
0.71 |
chr6_16399745_16399896 | 1.28 |
ENSG00000265642 |
. |
28934 |
0.24 |
chr14_102446732_102446883 | 1.28 |
DYNC1H1 |
dynein, cytoplasmic 1, heavy chain 1 |
15942 |
0.19 |
chr4_77752077_77752228 | 1.28 |
ENSG00000264124 |
. |
22965 |
0.17 |
chr22_36748127_36749442 | 1.28 |
MYH9 |
myosin, heavy chain 9, non-muscle |
12372 |
0.18 |
chr18_55094933_55095260 | 1.28 |
ONECUT2 |
one cut homeobox 2 |
7821 |
0.21 |
chr16_85018796_85019044 | 1.27 |
ZDHHC7 |
zinc finger, DHHC-type containing 7 |
3197 |
0.29 |
chr5_175299080_175299718 | 1.27 |
CPLX2 |
complexin 2 |
414 |
0.87 |
chrX_152992299_152993172 | 1.27 |
ABCD1 |
ATP-binding cassette, sub-family D (ALD), member 1 |
1463 |
0.23 |
chr7_101361818_101362221 | 1.26 |
MYL10 |
myosin, light chain 10, regulatory |
89443 |
0.08 |
chr16_57095019_57095389 | 1.26 |
RP11-322D14.2 |
|
2795 |
0.18 |
chr7_196076_196227 | 1.26 |
AC093627.12 |
|
1971 |
0.33 |
chr11_65627144_65627758 | 1.25 |
MUS81 |
MUS81 structure-specific endonuclease subunit |
82 |
0.86 |
chr15_83735985_83736600 | 1.25 |
BTBD1 |
BTB (POZ) domain containing 1 |
186 |
0.51 |
chr15_101807298_101807582 | 1.25 |
VIMP |
VCP-interacting membrane protein |
10052 |
0.15 |
chr22_21138211_21138628 | 1.25 |
SERPIND1 |
serpin peptidase inhibitor, clade D (heparin cofactor), member 1 |
4950 |
0.19 |
chr3_156526171_156526322 | 1.24 |
LEKR1 |
leucine, glutamate and lysine rich 1 |
17843 |
0.26 |
chr10_33522924_33523075 | 1.24 |
NRP1 |
neuropilin 1 |
20510 |
0.2 |
chr2_177646434_177646585 | 1.23 |
ENSG00000252027 |
. |
117105 |
0.06 |
chr12_2103135_2103380 | 1.22 |
DCP1B |
decapping mRNA 1B |
10379 |
0.14 |
chr4_189329906_189330057 | 1.22 |
RP11-366H4.3 |
|
265448 |
0.02 |
chr16_90124266_90124417 | 1.22 |
PRDM7 |
PR domain containing 7 |
4392 |
0.15 |
chr3_134085363_134085514 | 1.21 |
AMOTL2 |
angiomotin like 2 |
5316 |
0.24 |
chrX_119683710_119683861 | 1.21 |
ENSG00000272179 |
. |
5615 |
0.2 |
chr2_74804630_74805005 | 1.21 |
LOXL3 |
lysyl oxidase-like 3 |
22000 |
0.09 |
chr10_112206935_112207266 | 1.21 |
ENSG00000221359 |
. |
13101 |
0.19 |
chr2_238382943_238383402 | 1.19 |
MLPH |
melanophilin |
10899 |
0.2 |
chr10_6182182_6182929 | 1.19 |
PFKFB3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
4326 |
0.16 |
chr7_135426972_135427123 | 1.19 |
FAM180A |
family with sequence similarity 180, member A |
6413 |
0.17 |
chr1_25654478_25654629 | 1.18 |
TMEM50A |
transmembrane protein 50A |
9855 |
0.13 |
chr1_25689807_25689958 | 1.18 |
ENSG00000238889 |
. |
17014 |
0.12 |
chr13_109609770_109610065 | 1.18 |
MYO16 |
myosin XVI |
71400 |
0.13 |
chr2_118981232_118982329 | 1.17 |
INSIG2 |
insulin induced gene 2 |
135730 |
0.05 |
chr17_77788487_77789261 | 1.17 |
ENSG00000238331 |
. |
4396 |
0.16 |
chr17_76296960_76297664 | 1.17 |
SOCS3 |
suppressor of cytokine signaling 3 |
58843 |
0.08 |
chr1_215691193_215691481 | 1.17 |
KCTD3 |
potassium channel tetramerization domain containing 3 |
49398 |
0.19 |
chr10_69865393_69865544 | 1.17 |
MYPN |
myopalladin |
444 |
0.84 |
chr2_113569329_113569797 | 1.16 |
IL1B |
interleukin 1, beta |
24448 |
0.14 |
chr12_120306809_120306960 | 1.16 |
CIT |
citron (rho-interacting, serine/threonine kinase 21) |
8208 |
0.26 |
chr4_129520993_129521144 | 1.16 |
ENSG00000238802 |
. |
156113 |
0.04 |
chr13_30717630_30717841 | 1.15 |
ENSG00000266816 |
. |
63101 |
0.14 |
chr2_112913247_112913906 | 1.14 |
FBLN7 |
fibulin 7 |
3749 |
0.3 |
chr1_54685070_54685221 | 1.14 |
MRPL37 |
mitochondrial ribosomal protein L37 |
9526 |
0.13 |
chr11_130431461_130431612 | 1.14 |
C11orf44 |
chromosome 11 open reading frame 44 |
111315 |
0.06 |
chr12_106812825_106812976 | 1.14 |
POLR3B |
polymerase (RNA) III (DNA directed) polypeptide B |
37150 |
0.19 |
chr15_68835194_68835345 | 1.13 |
CORO2B |
coronin, actin binding protein, 2B |
36039 |
0.21 |
chr19_1855625_1856481 | 1.13 |
CTB-31O20.6 |
|
3655 |
0.1 |
chr17_66098511_66099312 | 1.13 |
LINC00674 |
long intergenic non-protein coding RNA 674 |
862 |
0.63 |
chr10_81915562_81915788 | 1.13 |
ANXA11 |
annexin A11 |
6093 |
0.21 |
chr7_73293941_73294092 | 1.12 |
WBSCR28 |
Williams-Beuren syndrome chromosome region 28 |
18527 |
0.16 |
chr10_96168902_96169053 | 1.12 |
TBC1D12 |
TBC1 domain family, member 12 |
6716 |
0.24 |
chr13_51191217_51191680 | 1.12 |
DLEU7-AS1 |
DLEU7 antisense RNA 1 |
190544 |
0.03 |
chr19_1253556_1254162 | 1.12 |
MIDN |
midnolin |
2238 |
0.14 |
chr15_45938643_45938794 | 1.12 |
SQRDL |
sulfide quinone reductase-like (yeast) |
639 |
0.72 |
chr11_65257627_65258285 | 1.11 |
SCYL1 |
SCY1-like 1 (S. cerevisiae) |
34592 |
0.08 |
chr7_44420326_44420477 | 1.11 |
CAMK2B |
calcium/calmodulin-dependent protein kinase II beta |
55146 |
0.12 |
chr12_111873433_111874308 | 1.10 |
SH2B3 |
SH2B adaptor protein 3 |
1204 |
0.47 |
chr17_58196541_58197053 | 1.10 |
CA4 |
carbonic anhydrase IV |
30500 |
0.12 |
chr7_129650015_129650166 | 1.10 |
RP11-306G20.1 |
|
1396 |
0.32 |
chr8_13316772_13316923 | 1.10 |
DLC1 |
deleted in liver cancer 1 |
39903 |
0.18 |
chr7_101457741_101458764 | 1.10 |
CUX1 |
cut-like homeobox 1 |
707 |
0.73 |
chr11_66214372_66214523 | 1.09 |
MRPL11 |
mitochondrial ribosomal protein L11 |
8128 |
0.08 |
chr1_26735326_26736045 | 1.09 |
LIN28A |
lin-28 homolog A (C. elegans) |
1584 |
0.28 |
chr18_34021368_34021519 | 1.08 |
FHOD3 |
formin homology 2 domain containing 3 |
103071 |
0.08 |
chr5_78191585_78191736 | 1.08 |
ARSB |
arylsulfatase B |
89948 |
0.09 |
chr9_96720941_96721916 | 1.08 |
BARX1 |
BARX homeobox 1 |
3774 |
0.31 |
chr6_108478878_108479576 | 1.08 |
OSTM1 |
osteopetrosis associated transmembrane protein 1 |
7817 |
0.19 |
chr6_148566282_148566579 | 1.08 |
SASH1 |
SAM and SH3 domain containing 1 |
27010 |
0.19 |
chr3_16225615_16225766 | 1.07 |
GALNT15 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15 |
9474 |
0.25 |
chr5_9057802_9057953 | 1.07 |
ENSG00000266415 |
. |
3870 |
0.33 |
chr17_1628296_1629053 | 1.07 |
WDR81 |
WD repeat domain 81 |
420 |
0.71 |
chr3_138679290_138679821 | 1.07 |
C3orf72 |
chromosome 3 open reading frame 72 |
13479 |
0.16 |
chr3_52039773_52040512 | 1.07 |
RPL29 |
ribosomal protein L29 |
10184 |
0.09 |
chr11_12831858_12832009 | 1.07 |
RP11-47J17.3 |
|
13281 |
0.21 |
chrX_3061337_3061668 | 1.06 |
ARSF |
arylsulfatase F |
76628 |
0.09 |
chr4_10095359_10096185 | 1.06 |
ENSG00000264931 |
. |
15456 |
0.14 |
chr12_93755060_93755211 | 1.06 |
ENSG00000239073 |
. |
10743 |
0.15 |
chr19_11529071_11529829 | 1.06 |
RGL3 |
ral guanine nucleotide dissociation stimulator-like 3 |
201 |
0.85 |
chr1_155952813_155953359 | 1.06 |
ARHGEF2 |
Rho/Rac guanine nucleotide exchange factor (GEF) 2 |
4196 |
0.11 |
chr12_98194430_98194581 | 1.06 |
ENSG00000206899 |
. |
79011 |
0.11 |
chr3_73776532_73776683 | 1.06 |
PDZRN3 |
PDZ domain containing ring finger 3 |
102516 |
0.07 |
chr1_181110732_181111665 | 1.05 |
IER5 |
immediate early response 5 |
53560 |
0.15 |
chr14_73082507_73082663 | 1.05 |
RGS6 |
regulator of G-protein signaling 6 |
156208 |
0.04 |
chr8_26497946_26498133 | 1.05 |
DPYSL2 |
dihydropyrimidinase-like 2 |
62118 |
0.14 |
chr6_33171905_33172311 | 1.05 |
HSD17B8 |
hydroxysteroid (17-beta) dehydrogenase 8 |
311 |
0.73 |
chr9_117612691_117612842 | 1.04 |
TNFSF15 |
tumor necrosis factor (ligand) superfamily, member 15 |
44360 |
0.16 |
chr6_33150940_33151371 | 1.04 |
COL11A2 |
collagen, type XI, alpha 2 |
9076 |
0.08 |
chr7_107635696_107635847 | 1.04 |
ENSG00000238297 |
. |
4656 |
0.19 |
chr4_157697446_157697659 | 1.03 |
RP11-154F14.2 |
|
64959 |
0.12 |
chr6_11433627_11433778 | 1.03 |
NEDD9 |
neural precursor cell expressed, developmentally down-regulated 9 |
51121 |
0.15 |
chr9_97574557_97574782 | 1.03 |
ENSG00000252153 |
. |
2425 |
0.27 |
chr17_7746157_7747127 | 1.02 |
KDM6B |
lysine (K)-specific demethylase 6B |
1591 |
0.22 |
chr1_7351911_7352062 | 1.02 |
ENSG00000207056 |
. |
72566 |
0.1 |
chr16_85169897_85170486 | 1.02 |
FAM92B |
family with sequence similarity 92, member B |
24077 |
0.18 |
chr8_129337181_129337332 | 1.02 |
ENSG00000201782 |
. |
104506 |
0.08 |
chr1_112937922_112938649 | 1.02 |
CTTNBP2NL |
CTTNBP2 N-terminal like |
518 |
0.81 |
chr14_68467342_68467493 | 1.02 |
CTD-2566J3.1 |
|
129496 |
0.05 |
chr9_117956749_117957045 | 1.01 |
DEC1 |
deleted in esophageal cancer 1 |
52800 |
0.16 |
chr5_167115956_167116107 | 1.01 |
CTB-78F1.1 |
|
28545 |
0.19 |
chr11_12307449_12307766 | 1.01 |
MICALCL |
MICAL C-terminal like |
840 |
0.61 |
chr6_36737609_36738089 | 1.00 |
CPNE5 |
copine V |
12663 |
0.19 |
chr12_52585492_52585885 | 1.00 |
KRT80 |
keratin 80 |
96 |
0.95 |
chr2_201474280_201474431 | 1.00 |
AOX1 |
aldehyde oxidase 1 |
21458 |
0.2 |
chr1_101109019_101109170 | 1.00 |
VCAM1 |
vascular cell adhesion molecule 1 |
76204 |
0.1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.4 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.3 | 1.0 | GO:0060424 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.3 | 1.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 1.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 0.9 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.3 | 1.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.3 | 0.3 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.3 | 1.1 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 1.3 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.2 | 1.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 0.7 | GO:0044415 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.2 | 0.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 0.7 | GO:0007132 | meiotic metaphase I(GO:0007132) |
0.2 | 0.6 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.2 | 0.6 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.2 | 1.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 0.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 0.6 | GO:1902170 | cellular response to nitric oxide(GO:0071732) cellular response to reactive nitrogen species(GO:1902170) |
0.2 | 1.0 | GO:0045628 | regulation of T-helper 2 cell differentiation(GO:0045628) |
0.2 | 1.1 | GO:0061001 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.2 | 0.9 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 0.6 | GO:0010761 | fibroblast migration(GO:0010761) |
0.2 | 0.5 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.2 | 0.7 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.2 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.2 | 1.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.2 | 0.5 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.2 | 0.5 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.2 | 0.2 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.2 | 0.3 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 1.0 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.2 | 0.5 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.5 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.1 | 0.1 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.1 | 0.9 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.6 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.3 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.1 | 0.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.3 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.4 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.1 | 0.5 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.5 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 0.9 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.1 | 0.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.4 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.4 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.1 | 0.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.5 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.1 | 0.4 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.6 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.4 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 1.1 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.3 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 | 0.4 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.1 | 0.3 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.6 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 0.1 | GO:0072193 | positive regulation of smooth muscle cell differentiation(GO:0051152) ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.1 | 0.5 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.3 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.1 | 0.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.2 | GO:0060426 | lung vasculature development(GO:0060426) |
0.1 | 0.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.3 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.2 | GO:0010193 | response to ozone(GO:0010193) |
0.1 | 0.3 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.2 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.8 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.1 | 1.1 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.2 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.1 | 0.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.5 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.1 | 0.3 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.1 | 0.3 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.1 | 1.0 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 0.2 | GO:0050942 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) |
0.1 | 0.3 | GO:0060014 | granulosa cell differentiation(GO:0060014) |
0.1 | 0.6 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.2 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.1 | 0.3 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 0.8 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.1 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.1 | 0.7 | GO:0031529 | ruffle organization(GO:0031529) |
0.1 | 0.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.3 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.6 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
0.1 | 0.2 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.1 | 0.6 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.3 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.4 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.1 | 0.1 | GO:0060433 | bronchus development(GO:0060433) |
0.1 | 0.5 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) regulation of sprouting angiogenesis(GO:1903670) |
0.1 | 0.3 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.4 | GO:0010224 | response to UV-B(GO:0010224) |
0.1 | 0.4 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.1 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.1 | 0.7 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.1 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.3 | GO:0048935 | peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.2 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 1.2 | GO:0043303 | mast cell activation involved in immune response(GO:0002279) mast cell degranulation(GO:0043303) |
0.1 | 0.2 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.4 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.1 | GO:0060197 | cloaca development(GO:0035844) cloacal septation(GO:0060197) |
0.1 | 0.2 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.1 | 0.2 | GO:0071692 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.2 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.2 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.2 | GO:0071436 | sodium ion export(GO:0071436) |
0.1 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 1.3 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.6 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 0.1 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.1 | 0.4 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.1 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.4 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.1 | 0.2 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.2 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 1.8 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.6 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.2 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.1 | 0.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.4 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.1 | GO:0071305 | cellular response to vitamin D(GO:0071305) |
0.1 | 0.1 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.1 | 0.2 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.2 | GO:0003416 | endochondral bone growth(GO:0003416) growth plate cartilage development(GO:0003417) bone growth(GO:0098868) |
0.1 | 0.1 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.1 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.3 | GO:0097531 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.1 | 0.5 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.4 | GO:0009200 | deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
0.1 | 0.2 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.1 | 0.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.1 | 0.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.5 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.4 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.1 | 0.3 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.1 | 0.1 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.2 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.2 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 0.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.1 | 0.2 | GO:0031507 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.1 | 0.2 | GO:0060438 | trachea development(GO:0060438) |
0.1 | 0.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.2 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.3 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 0.2 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.1 | 0.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 1.1 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.1 | 0.1 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.1 | 0.5 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 0.2 | GO:0050922 | negative regulation of chemotaxis(GO:0050922) |
0.1 | 0.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.1 | 0.3 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.2 | GO:0010587 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.1 | 0.2 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.1 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.2 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.1 | 0.1 | GO:0061525 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.1 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.7 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.2 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.5 | GO:0090398 | cellular senescence(GO:0090398) |
0.1 | 0.2 | GO:0006172 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.1 | 0.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.6 | GO:0010171 | body morphogenesis(GO:0010171) |
0.1 | 0.1 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.2 | GO:0016093 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.1 | 0.1 | GO:0042661 | mesodermal cell fate specification(GO:0007501) regulation of mesodermal cell fate specification(GO:0042661) regulation of mesoderm development(GO:2000380) negative regulation of gastrulation(GO:2000542) |
0.1 | 0.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.1 | GO:0045778 | positive regulation of ossification(GO:0045778) |
0.1 | 0.1 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 0.4 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.0 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) |
0.0 | 0.1 | GO:0051461 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.0 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.3 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.0 | 0.4 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.0 | 0.4 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.0 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.0 | 0.3 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.1 | GO:0052308 | pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response(GO:0052033) positive regulation by symbiont of host innate immune response(GO:0052166) modulation by symbiont of host innate immune response(GO:0052167) pathogen-associated molecular pattern dependent modulation by symbiont of host innate immune response(GO:0052169) pathogen-associated molecular pattern dependent induction by organism of innate immune response of other organism involved in symbiotic interaction(GO:0052257) positive regulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052305) modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052306) pathogen-associated molecular pattern dependent modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052308) positive regulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052555) positive regulation by symbiont of host immune response(GO:0052556) |
0.0 | 0.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.1 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.0 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.0 | 0.0 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.2 | GO:0051593 | response to folic acid(GO:0051593) |
0.0 | 0.3 | GO:0006390 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.0 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.0 | 0.2 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.1 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.0 | 0.1 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.0 | 0.1 | GO:0017000 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.2 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.2 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.0 | 0.0 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.1 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.0 | 0.2 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.0 | GO:0033483 | gas homeostasis(GO:0033483) |
0.0 | 0.1 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 0.3 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.0 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.0 | 0.4 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.1 | GO:0006573 | valine metabolic process(GO:0006573) |
0.0 | 0.2 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.0 | 0.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.3 | GO:0010092 | organ induction(GO:0001759) specification of organ identity(GO:0010092) |
0.0 | 0.1 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.3 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.2 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.0 | 0.1 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.0 | 0.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.0 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.2 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.0 | 0.2 | GO:0072659 | protein localization to plasma membrane(GO:0072659) protein localization to cell periphery(GO:1990778) |
0.0 | 0.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.2 | GO:0006853 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.0 | 0.0 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.2 | GO:0060968 | regulation of gene silencing(GO:0060968) |
0.0 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.2 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.0 | 0.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.0 | 0.2 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.2 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.5 | GO:0046134 | pyrimidine nucleoside biosynthetic process(GO:0046134) |
0.0 | 0.1 | GO:0044321 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.0 | 0.4 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.0 | 0.2 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.0 | 0.2 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.9 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
0.0 | 0.1 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.0 | 0.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.1 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.0 | 0.1 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.0 | 0.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.2 | GO:0007549 | dosage compensation(GO:0007549) |
0.0 | 0.1 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.0 | 0.5 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.1 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.0 | 0.3 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.3 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
0.0 | 0.3 | GO:0033189 | response to vitamin A(GO:0033189) |
0.0 | 0.3 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.0 | 0.1 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.0 | 0.4 | GO:0010510 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.0 | 0.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 | 0.2 | GO:0015851 | nucleobase transport(GO:0015851) |
0.0 | 0.1 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 0.2 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.2 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.4 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.0 | 0.2 | GO:0019368 | fatty acid elongation, unsaturated fatty acid(GO:0019368) |
0.0 | 0.0 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) pattern specification involved in metanephros development(GO:0072268) |
0.0 | 0.0 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.3 | GO:0036294 | cellular response to decreased oxygen levels(GO:0036294) cellular response to oxygen levels(GO:0071453) cellular response to hypoxia(GO:0071456) |
0.0 | 0.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.0 | 0.1 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.1 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.0 | 0.0 | GO:2000831 | corticosteroid hormone secretion(GO:0035930) regulation of steroid hormone secretion(GO:2000831) regulation of corticosteroid hormone secretion(GO:2000846) |
0.0 | 0.1 | GO:0001975 | response to amphetamine(GO:0001975) |
0.0 | 0.0 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
0.0 | 0.3 | GO:0021772 | olfactory bulb development(GO:0021772) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.0 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.1 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.0 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) positive regulation of meiotic cell cycle(GO:0051446) |
0.0 | 0.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.0 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.0 | 0.1 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.0 | 0.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.2 | GO:0048747 | muscle fiber development(GO:0048747) |
0.0 | 0.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.0 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.0 | 0.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.4 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.0 | 0.0 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.0 | 0.0 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.0 | 0.0 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.1 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.1 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.1 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.1 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.0 | 0.1 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.1 | GO:0045008 | depyrimidination(GO:0045008) |
0.0 | 0.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 0.1 | GO:0009648 | photoperiodism(GO:0009648) |
0.0 | 0.8 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.0 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.2 | GO:0034661 | ncRNA catabolic process(GO:0034661) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.3 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.1 | GO:0030277 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.3 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.1 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.1 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.0 | 0.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.0 | 0.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.1 | GO:0032616 | interleukin-13 production(GO:0032616) |
0.0 | 0.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.0 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 0.3 | GO:0050432 | catecholamine secretion(GO:0050432) |
0.0 | 0.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.1 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.0 | 0.1 | GO:0060428 | lung epithelium development(GO:0060428) |
0.0 | 0.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.3 | GO:0007045 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.0 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.1 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.0 | 0.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.3 | GO:0035195 | gene silencing by miRNA(GO:0035195) |
0.0 | 0.2 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.2 | GO:0007617 | mating behavior(GO:0007617) reproductive behavior(GO:0019098) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.0 | GO:0031050 | dsRNA fragmentation(GO:0031050) production of small RNA involved in gene silencing by RNA(GO:0070918) |
0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.0 | GO:0010871 | negative regulation of receptor biosynthetic process(GO:0010871) |
0.0 | 0.0 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.0 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.0 | 0.0 | GO:1903313 | regulation of mRNA 3'-end processing(GO:0031440) positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.0 | 0.2 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) endochondral bone morphogenesis(GO:0060350) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.3 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.0 | 0.1 | GO:0099518 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.0 | 0.0 | GO:0051135 | regulation of NK T cell activation(GO:0051133) positive regulation of NK T cell activation(GO:0051135) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.1 | GO:2001234 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.0 | 0.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi vesicle budding(GO:0048194) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.0 | 0.1 | GO:0030858 | positive regulation of epithelial cell differentiation(GO:0030858) |
0.0 | 0.1 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.0 | 0.5 | GO:0007613 | memory(GO:0007613) |
0.0 | 0.2 | GO:0098876 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.0 | 0.1 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.5 | GO:0007041 | lysosomal transport(GO:0007041) |
0.0 | 0.0 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.0 | 0.1 | GO:0001885 | endothelial cell development(GO:0001885) |
0.0 | 0.1 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 | 0.2 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.0 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.0 | 0.1 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.1 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.0 | 0.0 | GO:0071028 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.1 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.0 | 0.3 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.0 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.0 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.0 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.0 | GO:0055093 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.0 | 0.6 | GO:0060538 | skeletal muscle organ development(GO:0060538) |
0.0 | 0.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.0 | 0.2 | GO:0016577 | histone demethylation(GO:0016577) |
0.0 | 0.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.3 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.1 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.0 | 0.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.0 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.0 | 0.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.3 | GO:0045739 | positive regulation of DNA repair(GO:0045739) positive regulation of response to DNA damage stimulus(GO:2001022) |
0.0 | 0.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.2 | GO:0090659 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.1 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.0 | 0.0 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.0 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.1 | GO:0060349 | bone morphogenesis(GO:0060349) |
0.0 | 0.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.0 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.4 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
0.0 | 0.0 | GO:0060872 | reflex(GO:0060004) semicircular canal development(GO:0060872) |
0.0 | 0.3 | GO:1900372 | negative regulation of cyclic nucleotide metabolic process(GO:0030800) negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) negative regulation of nucleotide biosynthetic process(GO:0030809) negative regulation of cAMP metabolic process(GO:0030815) negative regulation of cAMP biosynthetic process(GO:0030818) negative regulation of purine nucleotide biosynthetic process(GO:1900372) |
0.0 | 0.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.1 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.0 | 0.2 | GO:0009435 | NAD biosynthetic process(GO:0009435) nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.0 | 0.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.0 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.0 | GO:0090399 | replicative senescence(GO:0090399) |
0.0 | 0.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.0 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.1 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.1 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.1 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.2 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.0 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.0 | 0.2 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.0 | 0.1 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.0 | 0.2 | GO:0030010 | establishment of cell polarity(GO:0030010) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.5 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.0 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.0 | 0.3 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.3 | GO:0097480 | synaptic vesicle transport(GO:0048489) synaptic vesicle localization(GO:0097479) establishment of synaptic vesicle localization(GO:0097480) |
0.0 | 0.1 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.3 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.6 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.0 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.0 | GO:0031427 | response to methotrexate(GO:0031427) |
0.0 | 0.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.0 | GO:0055025 | positive regulation of cardiac muscle tissue growth(GO:0055023) positive regulation of cardiac muscle tissue development(GO:0055025) positive regulation of cardiac muscle cell proliferation(GO:0060045) |
0.0 | 0.1 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.1 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.1 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.0 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.1 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.0 | 0.0 | GO:2000189 | regulation of cholesterol homeostasis(GO:2000188) positive regulation of cholesterol homeostasis(GO:2000189) |
0.0 | 0.0 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.3 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.1 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.1 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.2 | GO:0009584 | detection of visible light(GO:0009584) |
0.0 | 0.0 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 0.2 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.0 | 0.0 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.0 | 0.0 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 0.0 | GO:0051307 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.0 | 0.1 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.0 | 0.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.1 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.2 | GO:0017156 | calcium ion regulated exocytosis(GO:0017156) |
0.0 | 0.1 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.0 | 0.0 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.0 | 0.0 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.0 | 0.1 | GO:0006282 | regulation of DNA repair(GO:0006282) |
0.0 | 0.0 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.3 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 0.0 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.0 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.0 | GO:0060457 | negative regulation of digestive system process(GO:0060457) |
0.0 | 0.1 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.1 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.0 | 0.0 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.0 | 0.4 | GO:0006821 | chloride transport(GO:0006821) |
0.0 | 0.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.1 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.0 | 0.2 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.0 | 0.2 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.0 | 0.1 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.0 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.0 | 0.0 | GO:0072070 | loop of Henle development(GO:0072070) |
0.0 | 0.0 | GO:0034372 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.0 | 0.1 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.1 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.0 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.0 | 0.1 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
0.0 | 0.1 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.0 | GO:0019731 | antimicrobial humoral response(GO:0019730) antibacterial humoral response(GO:0019731) |
0.0 | 0.0 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.1 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.0 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.1 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.0 | 0.0 | GO:0043084 | penile erection(GO:0043084) |
0.0 | 0.0 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.2 | GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0090101) |
0.0 | 0.0 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.0 | 0.1 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.0 | 0.0 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.0 | 0.0 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.0 | 0.3 | GO:0007631 | feeding behavior(GO:0007631) |
0.0 | 0.0 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.0 | 0.0 | GO:0042228 | interleukin-8 biosynthetic process(GO:0042228) |
0.0 | 0.0 | GO:0030147 | obsolete natriuresis(GO:0030147) |
0.0 | 0.0 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.0 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.0 | 0.0 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.0 | 1.1 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.0 | GO:0061035 | regulation of cartilage development(GO:0061035) |
0.0 | 0.3 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.1 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.1 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.0 | 0.0 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.0 | GO:0042117 | monocyte activation(GO:0042117) |
0.0 | 0.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.5 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.2 | 0.7 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 0.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 1.7 | GO:0002102 | podosome(GO:0002102) |
0.2 | 1.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.6 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.2 | 0.5 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.2 | 0.5 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 1.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 0.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.4 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 1.1 | GO:0030122 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.4 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 1.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 1.0 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.1 | 0.5 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 0.5 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.3 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 0.3 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.1 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.4 | GO:0002178 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 2.9 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.6 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 0.5 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.1 | 0.8 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.3 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.4 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 1.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 1.0 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.7 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 3.0 | GO:0044309 | neuron spine(GO:0044309) |
0.1 | 0.3 | GO:0043230 | extracellular organelle(GO:0043230) |
0.1 | 0.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.4 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.1 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 0.2 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 1.4 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 0.3 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.2 | GO:0001740 | Barr body(GO:0001740) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.2 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 1.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.2 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.1 | GO:0042597 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.0 | 0.3 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 2.0 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.4 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.1 | GO:0031083 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.0 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.2 | GO:0043256 | laminin complex(GO:0043256) |
0.0 | 8.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 2.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.1 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 0.3 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 2.2 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 1.6 | GO:0030017 | sarcomere(GO:0030017) |
0.0 | 0.2 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 1.3 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.5 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 1.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 1.3 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.1 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.0 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 1.1 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.3 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.1 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.8 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.1 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.0 | 0.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.2 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.4 | GO:0032155 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
0.0 | 0.8 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.1 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.0 | 0.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 1.6 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 1.5 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 1.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 1.4 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.2 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.9 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.3 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 0.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.1 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.0 | 0.3 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.1 | GO:0045273 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.1 | GO:0036126 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.0 | 0.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.1 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.0 | 0.2 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.1 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.0 | 0.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.0 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.0 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.4 | 1.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 1.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.3 | 0.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 2.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 1.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.6 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.2 | 0.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.2 | 0.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 0.7 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.2 | 1.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.2 | 0.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 0.6 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 0.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 0.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.6 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 0.6 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 1.0 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.4 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 1.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 1.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.4 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.1 | 0.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.4 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.4 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.9 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.1 | 0.7 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.4 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.4 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 0.5 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.1 | 1.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.5 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.6 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.3 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.7 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 0.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 1.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.6 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.1 | 0.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.4 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.7 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.3 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.2 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.3 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.4 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.1 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.2 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.6 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.2 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.1 | 0.8 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.4 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.3 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.1 | 0.4 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.2 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.3 | GO:0031545 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.4 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 1.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 2.4 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 1.0 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.1 | 0.3 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.2 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 1.1 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 0.6 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.1 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.3 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.2 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.2 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.1 | 0.6 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.9 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.3 | GO:0070700 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) BMP receptor binding(GO:0070700) |
0.1 | 0.5 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.7 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.3 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.1 | 0.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.4 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.4 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.8 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.1 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.1 | 0.5 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.3 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 2.4 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.2 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.2 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.1 | 0.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 1.4 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.2 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.2 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 0.5 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 0.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.1 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.0 | 0.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.1 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.3 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.0 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.0 | 1.0 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.2 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.0 | 0.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.2 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 2.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.3 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.2 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.3 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.3 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.0 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.4 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.2 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 0.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.2 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.0 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.2 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.0 | 0.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.2 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.4 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.3 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.0 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.3 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.5 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.1 | GO:0019798 | procollagen-proline dioxygenase activity(GO:0019798) |
0.0 | 0.1 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.2 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.0 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.0 | 0.2 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.1 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.4 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.1 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.0 | 0.7 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.6 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.0 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.1 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.1 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.2 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 0.3 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.2 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.0 | 0.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.0 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 0.1 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.4 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 0.3 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.3 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.4 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.4 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.1 | GO:0044620 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.0 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.4 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.1 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.2 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.0 | 0.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.2 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.0 | 0.1 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 1.0 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.0 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.1 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.0 | 0.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.0 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.0 | GO:0052659 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.0 | 0.1 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.0 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.3 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.3 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.1 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.0 | 0.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.0 | 0.5 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.0 | GO:0030249 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.0 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.0 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 1.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.1 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.3 | GO:0042562 | hormone binding(GO:0042562) |
0.0 | 0.0 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
0.0 | 0.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.0 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.1 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.1 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.0 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 1.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 1.3 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.4 | GO:0019199 | transmembrane receptor protein kinase activity(GO:0019199) |
0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.0 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.7 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.0 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.1 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.0 | 0.1 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.0 | 0.0 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.8 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.1 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.0 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.1 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.1 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.2 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.0 | GO:0047115 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
0.0 | 0.0 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.0 | 0.4 | GO:0036459 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.0 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 0.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 1.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 2.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 2.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 3.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 2.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 2.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 1.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.8 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 2.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.0 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.6 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 1.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.6 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 4.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 3.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.0 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 2.5 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.9 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 2.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 2.0 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 1.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 4.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 0.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.6 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 0.9 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 0.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 1.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 1.0 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 1.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.9 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 1.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.5 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.1 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.0 | 0.4 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.0 | 0.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.8 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.4 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.3 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.0 | 0.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 0.0 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.0 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.0 | 0.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.8 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.1 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.0 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.2 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.1 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
0.0 | 0.2 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.3 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.9 | REACTOME MEMBRANE TRAFFICKING | Genes involved in Membrane Trafficking |
0.0 | 0.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.1 | REACTOME SIGNALLING TO ERKS | Genes involved in Signalling to ERKs |
0.0 | 0.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.1 | REACTOME PI 3K CASCADE | Genes involved in PI-3K cascade |
0.0 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 0.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.0 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 0.1 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.1 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.0 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.1 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.0 | 0.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |